| Overview |
| bsm-2271M-PE-Cy5 |
| CMV(1F11) Monoclonal Antibody, PE-Cy5 Conjugated |
| WB |
| Virus, Others |
| Specifications |
| PE-Cy5 |
| Mouse |
| Recombinant Protein HCMV |
| Monoclonal |
| 1F11 |
| IgG |
| 1ug/ul |
| Purified by Protein G. |
| Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol. |
| Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles. |
| Target |
| CMV; Cytomegalovirus; CMV glycoprotein B; CMV glycoprotein GP55; Cytomegalovirus glycoprotein GP55; gB; Glycoprotein B; Glycoprotein GP55; HCMV; HCMV glycoprotein B; HCMV glycoprotein GP55; HHV 5; HHV 5 glycoprotein B; HHV 5 glycoprotein GP55; HHV5 glycoprotein B; HHV5 glycoprotein GP55; Human herpesvirus 5 glycoprotein B; Human herpesvirus 5 glycoprotein GP55; UL55. |
| Human cytomegalovirus (HCMV) glycoprotein B (gB) is an abundant virion envelope protein that has been shown to be essential for the infectivity of HCMV. HCMV gB is also one of the most immunogenic virus-encoded proteins, and a significant fraction of virus neutralizing are directed at gB. |
| Application Dilution |
| WB |
1:300-5000 |